Dosimetric predictors of diarrhea during radiotherapy for prostate cancerDosimetrische Prädiktoren einer Diarrhö bei Bestrahlung von Prostatakarzinomen

[1] Cavey M.L.(2005)IMRT to escalate the dose to the prostate while treating the pelvic nodes Strahlenther Onkol 181 431-41

[2] Bayouth J.E.(2007)Local high-dose radiotherapy and sparing of normal tissue using intensity-modulated radiotherapy (IMRT) for mucosal melanoma of the nasal cavity and paranasal sinuses Strahlenther Onkol 183 63-8

[3] Colman M.(1994)Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 30 323-9

[4] Combs S.E.(1991)Tolerance of normal tissue to therapeutic irradiation Int J Radiat Oncol Biol Phys 21 109-22

[5] Konkel S.(2002)Rectum contouring variability in patients treated for prostate cancer: impact on rectum dose-volume histograms and normal tissue complication probability Radiother Oncol 63 249-55

[6] Thilmann C.(2006)Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy Acta Oncol 45 717-27

[7] Diaz A.(1995)Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study J Clin Oncol 13 1303-11

[8] Roach M.(2002)Margins for geometric uncertainty around organs at risk in radiotherapy Radiother Oncol 62 299-307

[9] Marquez C.(2007)Normal tissue tolerance dose metrics for radiation therapy of major organs Semin Radiat Oncol 17 131-40

[10] Emami B.(2005)Testing the new ICRU 62 “Planning Organ at Risk Volume” concept for the rectum Radiother Oncol 75 293-302

[1] Cavey M.L.(2005)IMRT to escalate the dose to the prostate while treating the pelvic nodes Strahlenther Onkol 181 431-41

[2] Bayouth J.E.(2007)Local high-dose radiotherapy and sparing of normal tissue using intensity-modulated radiotherapy (IMRT) for mucosal melanoma of the nasal cavity and paranasal sinuses Strahlenther Onkol 183 63-8

[3] Colman M.(1994)Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 30 323-9

[4] Combs S.E.(1991)Tolerance of normal tissue to therapeutic irradiation Int J Radiat Oncol Biol Phys 21 109-22

[5] Konkel S.(2002)Rectum contouring variability in patients treated for prostate cancer: impact on rectum dose-volume histograms and normal tissue complication probability Radiother Oncol 63 249-55

[6] Thilmann C.(2006)Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy Acta Oncol 45 717-27

[7] Diaz A.(1995)Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study J Clin Oncol 13 1303-11

[8] Roach M.(2002)Margins for geometric uncertainty around organs at risk in radiotherapy Radiother Oncol 62 299-307

[9] Marquez C.(2007)Normal tissue tolerance dose metrics for radiation therapy of major organs Semin Radiat Oncol 17 131-40

[10] Emami B.(2005)Testing the new ICRU 62 “Planning Organ at Risk Volume” concept for the rectum Radiother Oncol 75 293-302